New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold season
By MATTHEW PERRONEAssociated Press WASHINGTON (AP) – U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year. The Food…
Read More